Baudax Bio Reports Second Quarter 2022 Financial Results and Business Highlights
ANJESO® Net Product Revenue Up 49% Year-Over-Year; Vials Sold to End-Users Up 67% Year-Over-Year Dosing…
Month: August 2022
Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
TSHA-120 treated patients in GAN demonstrated durable improvement and recoverability of sensory nerve amplitude potential…
Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights
– Enrollment of Phase 1B clinical trial of SL-172154 in combination with liposomal doxorubicin in…
Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results
— Strong cash position with $54.8 million of cash and cash equivalents as of June 30,…
ASLAN Pharmaceuticals Announces Three Abstracts Highlighting New Eblasakimab Data Have Been Accepted as E-Posters at the 31st European Academy of Dermatology and Venereology (EADV) Congress
MENLO PARK, Calif. and SINGAPORE, Aug. 11, 2022 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ: ASLN),…
Acasti Pharma Reports First Quarter 2023 Operational Results
Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Aug. 11, 2022 (GLOBE…
Finch Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
On track to proceed with enrollment in PRISM4 Phase 3 trial of CP101 in recurrent…
Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update
Topline data from 12-week Phase 1b trial in subjects with obesity/overweight and non-alcoholic fatty liver…
RVL Pharmaceuticals plc Reports Second Quarter 2022 Financial Results; Provides Commercial Update
— Second quarter 2022 UPNEEQ® net product sales of $8.4 million; 42% above first quarter…
Affimed Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Progress
AFM13 monotherapy: On track to report topline data of the registration-directed REDIRECT trial in the…
Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories
—Sabizabulin for COVID-19 Emergency Use Authorization Application Submitted to U.S. FDA in June 2022– –The…
Matinas BioPharma Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
75% of Patients Enrolled to Date in Cohort 4 of EnACT (MAT2203 in Cryptococcal Meningitis);…
“DAO Operating System” The Summon Platform Shows Strong Momentum Ahead of First Community Utility Token Distribution
The ultimate “DAO operating system” solution for DAO creation and management, The Summon Platform, shows…
Cloudbeds Publishes ‘Big Book of OTAs,’ Unveils Top Performing Distribution Channels and Strategic Guide to Driving Growth
Award-winning hospitality tech company releases comprehensive directory of 75+ top revenue-generating online travel agencies (OTAs),…
Kiteworks Launches the Private Content Network
A New Platform Approach to Zero-trust Protection and Compliance for Sensitive, Unstructured Data Communications PALO…
New Release of Ambassador Cloud Helps Kubernetes Developer Teams Move Faster
New features available in Ambassador Edge Stack and Telepresence accelerate self-service developer team productivity with…
Virtru demonstrates SecureCycle application at DEF CON 30
Built on OpenTDF, SecureCycle reveals the power of end-to-end encryption to grant people complete, sovereign…
Fandifi to Host Live Corporate Webinar and Introduce Fan Engagement Technology at 11am ET
David Vinokurov, President & CEO, will provide a corporate overview via a live presentation followed…
Sylogist Reports Strong Q3 Fiscal 2022 Results with Solid Organic Growth, Dividend Declared
Calgary, Alberta–(Newsfile Corp. – August 11, 2022) – Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the…
Plurilock’s Aurora Systems Receives US$3 Million in Purchase Orders for July 2022
Series of orders demonstrates Plurilock’s consistency and continued outstanding sales performance across key industry verticals…